Federal award (DEFINITIVE CONTRACT, fiscal year 2021)
Recipient: ANTIRADICAL THERAPEUTICS LLC
Awarding agency: Department of Defense / Department of the Army
Funding agency: Department of Defense / Department of the Army
Period of performance: 2018-12-03 to 2023-09-05
Current total value of award: $942513.53
Description: ADDITION OF CLIN 0003 FOR SETTLEMENT PAYMENT TO THE AWARD OF ART'S DHA SBIR PHASE II MEDICAL R&D CONTRACT FOR "SANFLOW: A THERAPEUTIC AGENT FOR USE IN THE FIELD FOR TRAUMATIC BRAIN INJURY"